ENTITY
Celltrion

Celltrion (068270 KP)

25
Analysis
Health Care • South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
bearish•Celltrion Inc
•14 Aug 2018 07:09

Celltrion (068270): Time Is Not Right for Short Sellers Yet

First, let me tell you this. I'm also a Celltrion basher. I don't like their accounting practices and dual company structure. Not only that,...

Logo
511 Views
Share
bearish•Celltrion Inc
•08 Aug 2018 03:59

Celltrion: Manufacturing Risks Remain

Celltrion Inc (068270 KS) continues to struggle with meeting the USFDA's standards for Good Manufacturing Practices. The agency issued a Form 483...

Share
bearish•Celltrion Inc
•26 Jul 2018 11:26

Sell Celltrion Inc (068270 KS): Story Unravelling

UPDATE: J&J release Q2 results - 24th July 2018 J&J’s US Remicade sales were flat QoQ. This undermines the story that Celltrion Group is...

bearish•Hyundai Motor
•24 Jul 2018 13:15

Updates on Korea's Chaebol Reforms - Proposed Revisions of the Fair Trade Act Were Specified

On 6 July 2018, a public hearing on proposed revisions of the Fair Trade Act was held. In my earlier insight Korean Conglomerates Likely to Embark...

Logo
544 Views
Share
bullish•SK Inc
•14 Jul 2018 10:38

SK Holdings (034730 KS): AMPAC Acquisition - Summary & Ramifications

SK Holdings Co Ltd (034730 KS) said in a regulatory filing that it had acquired a 100% stake in Fine Chemicals Holdings Corp. which is the parent...

Logo
831 Views
Share
x